Critical Questions in Choosing EGFR-Targeted Therapies for NSCLC - Episode 5

The Multidisciplinary Team’s Role in EGFRm NSCLC Management

,

Panelists discuss how a multidisciplinary team (MDT) plays a crucial role in managing EGFR-mutant non–small cell lung cancer (NSCLC) by integrating expertise from oncology, pathology, radiology, and surgery to optimize diagnosis, treatment, and monitoring. MDT collaboration ensures personalized, evidence-based care, enhancing patient outcomes.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Brief Overview of the Treatment Landscape of First-Line EGFRm NSCLC
    EP. 2: FLAURA, FLAURA2, and MARIPOSA: Key Takeaways to Impact First-Line Treatment Approach
    EP. 3: Clinical Factors to Consider When Choosing a Treatment Strategy
    EP. 4: Treatment Strategies to Manage AEs in EGFRm NSCLC
    Now Viewing
    EP. 5: The Multidisciplinary Team’s Role in EGFRm NSCLC Management
    EP. 6: Role of Rebiopsy at Disease Progression in EGFRm NSCLC
    EP. 7: Treatment Sequencing in Disease Progression in EGFRm NSCLC
    EP. 8: Looking Into the Future and at Unmet Needs in EGFRm NSCLC

    Video content above is prompted by the following:

    When using combination therapy up front, what have been your key learnings about managing adverse events and maintaining quality of life?

    x